Home
NEO
NEO News

Latest NeoGenomics Inc. (NEO) News on July 3, 2025

Argus Research

8 days ago

NEO: What does Argus have to say about NEO?

5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call

StockStory

8 days ago

5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call

NeoGenomics Appoints Dr. Marjorie Green to Board of Directors

Business Wire

9 days ago

NeoGenomics Appoints Dr. Marjorie Green to Board of Directors

3 Cash-Burning Stocks Facing Headwinds

StockStory

17 days ago

3 Cash-Burning Stocks Facing Headwinds

3 Unprofitable Stocks in Hot Water

StockStory

22 days ago

3 Unprofitable Stocks in Hot Water

Argus Research

22 days ago

NEO: What does Argus have to say about NEO?

Testing & Diagnostics Services Stocks Q1 Teardown: Quest (NYSE:DGX) Vs The Rest

StockStory

a month ago

Testing & Diagnostics Services Stocks Q1 Teardown: Quest (NYSE:DGX) Vs The Rest

3 Volatile Stocks in Hot Water

StockStory

a month ago

3 Volatile Stocks in Hot Water

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025

Business Wire

a month ago

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025

Firing on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the Way

StockStory

a month ago

Firing on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the Way

NeoGenomics introduces c-MET companion diagnostic for NSCLC

Medical Device Network

a month ago

NeoGenomics introduces c-MET companion diagnostic for NSCLC

NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer

Business Wire

a month ago

NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer

Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know

StockStory

a month ago

Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know

NeoGenomics to Participate in Upcoming June Investor Conferences

Business Wire

a month ago

NeoGenomics to Participate in Upcoming June Investor Conferences

3 Healthcare Stocks with Mounting Challenges

StockStory

a month ago

3 Healthcare Stocks with Mounting Challenges

MT Newswires

2 months ago

Guggenheim Initiates Coverage on NeoGenomics With Neutral Rating

3 Russell 2000 Stocks in the Doghouse

StockStory

2 months ago

3 Russell 2000 Stocks in the Doghouse

Argus Research

2 months ago

NEO: Rating increased to a HOLD

NEO Q1 Earnings Call: Sales Growth, Pharma Headwinds, and Pathline Integration Shape Outlook

StockStory

2 months ago

NEO Q1 Earnings Call: Sales Growth, Pharma Headwinds, and Pathline Integration Shape Outlook

Chief Financial Officer of NeoGenomics Jeffrey Sherman Buys 14% More Shares

Simply Wall St.

2 months ago

Chief Financial Officer of NeoGenomics Jeffrey Sherman Buys 14% More Shares

Argus Research

2 months ago

NEO: Raising target price to $6.00

NeoGenomics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 months ago

NeoGenomics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Small-Cap Stocks Walking a Fine Line

StockStory

2 months ago

3 Small-Cap Stocks Walking a Fine Line

MT Newswires

2 months ago

NeoGenomics Repays $201.3 Million Convertible Senior Notes

NeoGenomics price target lowered to $10 from $17 at Morgan Stanley

TipRanks

2 months ago

NeoGenomics price target lowered to $10 from $17 at Morgan Stanley

NeoGenomics Pays Off 1.25% Convertible Senior Notes

Business Wire

2 months ago

NeoGenomics Pays Off 1.25% Convertible Senior Notes

MT Newswires

2 months ago

Leerink Partners Downgrades NeoGenomics to Market Perform From Outperform, Lowers Price Target to $9 From $25

GuruFocus.com

2 months ago

NeoGenomics Inc (NEO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Why NeoGenomics (NEO) Stock Is Nosediving

StockStory

2 months ago

Why NeoGenomics (NEO) Stock Is Nosediving

MT Newswires

2 months ago

Needham Cuts NeoGenomics' Price Target to $8.50 From $18, Maintains Buy Rating

MT Newswires

2 months ago

NeoGenomics Expands Cancer Test Offerings With Ultima Genomics Collaboration

MT Newswires

2 months ago

NeoGenomics Posts Q1 Breakeven Adjusted Earnings as Revenue Rises; 2025 Guidance Updated

NeoGenomics (NEO) Reports Break-Even Earnings for Q1

Zacks

2 months ago

NeoGenomics (NEO) Reports Break-Even Earnings for Q1

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform

PR Newswire

2 months ago

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform

NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops

StockStory

2 months ago

NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops

Associated Press Finance

2 months ago

NeoGenomics: Q1 Earnings Snapshot

NeoGenomics Reports First Quarter 2025 Results

Business Wire

2 months ago

NeoGenomics Reports First Quarter 2025 Results

NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For

StockStory

2 months ago

NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

Zacks

2 months ago

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

2 months ago

NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

Business Wire

2 months ago

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

Argus Research

3 months ago

NEO: Rating decreased to a SELL

MT Newswires

3 months ago

BofA Securities Adjusts Price Target on NeoGenomics to $12 From $16, Maintains Neutral Rating

Argus Research

3 months ago

NEO: Lowering target price to $9.00

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

Business Wire

3 months ago

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

MT Newswires

3 months ago

NeoGenomics Closes Pathline Acquisition

NeoGenomics Completes Acquisition of Pathline

Business Wire

3 months ago

NeoGenomics Completes Acquisition of Pathline

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

StockStory

3 months ago

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

Argus Research

3 months ago

NEO: What does Argus have to say about NEO?

MT Newswires

3 months ago

NeoGenomics Appoints Tony Zook Chief Executive

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

Business Wire

3 months ago

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack

StockStory

3 months ago

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack

Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses

StockStory

3 months ago

Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses

3 Reasons to Sell NEO and 1 Stock to Buy Instead

StockStory

3 months ago

3 Reasons to Sell NEO and 1 Stock to Buy Instead

MT Newswires

3 months ago

NeoGenomics Names Warren Stone President, COO

NeoGenomics Appoints Warren Stone as President & Chief Operating Officer

Business Wire

3 months ago

NeoGenomics Appoints Warren Stone as President & Chief Operating Officer

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)

StockStory

4 months ago

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)

3 Small-Cap Stocks in Hot Water

StockStory

4 months ago

3 Small-Cap Stocks in Hot Water

MT Newswires

4 months ago

NeoGenomics Acquires Pathline

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

Business Wire

4 months ago

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

Argus Research

4 months ago

NEO: Lowering target price to $10.00

3 Healthcare Stocks Skating on Thin Ice

StockStory

4 months ago

3 Healthcare Stocks Skating on Thin Ice

Argus Research

4 months ago

NEO: Lowering target price to $11.00

NeoGenomics to Participate in Upcoming Investor Conferences

Business Wire

4 months ago

NeoGenomics to Participate in Upcoming Investor Conferences

NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

4 months ago

NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations

GuruFocus.com

4 months ago

NeoGenomics Inc (NEO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Neogenomics Inc Earnings Call

Argus Research

4 months ago

NEO: Lowering target price to $13.00

Why NeoGenomics (NEO) Shares Are Trading Lower Today

StockStory

4 months ago

Why NeoGenomics (NEO) Shares Are Trading Lower Today

NeoGenomics (NEO) Tops Q4 Earnings Estimates

Zacks

4 months ago

NeoGenomics (NEO) Tops Q4 Earnings Estimates

MT Newswires

4 months ago

NeoGenomics Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued -- Shares Drop Pre-Bell

Associated Press Finance

4 months ago

NeoGenomics: Q4 Earnings Snapshot

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets

StockStory

4 months ago

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

Business Wire

4 months ago

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect

StockStory

5 months ago

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect

Thomson Reuters StreetEvents

5 months ago

Q4 2024 Adaptive Biotechnologies Corp Earnings Call

Argus Research

5 months ago

NEO: Lowering target price to $15.00

MT Newswires

5 months ago

Pacific Biosciences of California Appoints NeoGenomics CEO to Board of Directors

PacBio Announces Appointment of Chris Smith to Board of Directors

GlobeNewswire

5 months ago

PacBio Announces Appointment of Chris Smith to Board of Directors

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

Business Wire

5 months ago

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

Argus Research

5 months ago

NEO: Raising target price to $16.00

Strong week for NeoGenomics (NASDAQ:NEO) shareholders doesn't alleviate pain of five-year loss

Simply Wall St.

5 months ago

Strong week for NeoGenomics (NASDAQ:NEO) shareholders doesn't alleviate pain of five-year loss

Argus Research

5 months ago

NEO: Raising target price to $15.00

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

Investor's Business Daily

6 months ago

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

MT Newswires

6 months ago

NeoGenomics Provides 2025 Revenue Outlook

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

Business Wire

6 months ago

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?

Zacks

6 months ago

NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?

Argus Research

6 months ago

NEO: Lowering target price to $14.00

MT Newswires

6 months ago

Adaptive Biotechnologies, NeoGenomics to Support Minimal Residual Disease Monitoring Options for Blood Cancer Patients

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

GlobeNewswire

6 months ago

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

MT Newswires

6 months ago

Benchmark Downgrades NeoGenomics to Hold From Buy

MT Newswires

6 months ago

NeoGenomics Appoints Tony Zook as CEO

NeoGenomics Announces Chief Executive Officer Succession

Business Wire

6 months ago

NeoGenomics Announces Chief Executive Officer Succession

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Business Wire

6 months ago

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

NeoGenomics (NEO) Upgraded to Buy: Here's Why

Zacks

6 months ago

NeoGenomics (NEO) Upgraded to Buy: Here's Why

Argus Research

6 months ago

NEO: Lowering target price to $17.00

Argus Research

7 months ago

NEO: Rating increased to a HOLD

MT Newswires

7 months ago

Natera Expands Lawsuit Against NeoGenomics to Include Additional Patent

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

Business Wire

7 months ago

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

Argus Research

7 months ago

NEO: Raising target price to $17.00

Share on Social Networks: